29 April 2026 : Database Analysis
Telomerase-Associated Genes as Prognostic Markers in High-Grade Serous Ovarian Cancer
Xiaohua Wang
ABCEG 1, Shuyu Han CDF 1, Xi Wang BC 1, Yanwei Guo ACDEF 2*
DOI: 10.12659/MSM.951804
Med Sci Monit 2026; 32:e951804
Table 1 Clinicopathologic characteristics in TCGA-OV dataset of patients with high-grade serous ovarian cancer.
| Characteristics | Number of patients (%) |
|---|---|
| Age (y) | |
| ≤60 | 228 (54.29%) |
| >60 | 192 (45.71%) |
| Race category | |
| American Indian or Alaska Native | 2 (0.48%) |
| Asian | 12 (2.85%) |
| Black or African American | 23 (5.48%) |
| White | 383 (91.19%) |
| FIGO stage | |
| Stage I | 4 (0.95%) |
| Stage II | 16 (3.81%) |
| Stage III | 328 (78.10%) |
| Stage IV | 72 (17.14%) |
| Patient’s vital status | |
| Alive | 131 (31.19%) |
| Dead | 289 (68.81%) |
| TCGA-OV – the Cancer Genome Atlas, ovarian carcinoma. | |